NimesulideNon-steroidal anti-inflammatory drug CAS# 51803-78-2 |
2D Structure
- Imatinib Mesylate (STI571)
Catalog No.:BCC1115
CAS No.:220127-57-1
- Dasatinib (BMS-354825)
Catalog No.:BCC1281
CAS No.:302962-49-8
- Saracatinib (AZD0530)
Catalog No.:BCC1166
CAS No.:379231-04-6
- Nilotinib(AMN-107)
Catalog No.:BCC3643
CAS No.:641571-10-0
- Ponatinib (AP24534)
Catalog No.:BCC2522
CAS No.:943319-70-8
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 51803-78-2 | SDF | Download SDF |
PubChem ID | 4495 | Appearance | Powder |
Formula | C13H12N2O5S | M.Wt | 308.31 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | R805 | ||
Solubility | DMSO : ≥ 100 mg/mL (324.35 mM) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | N-(4-nitro-2-phenoxyphenyl)methanesulfonamide | ||
SMILES | CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2 | ||
Standard InChIKey | HYWYRSMBCFDLJT-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective, orally active cyclooxygenase-2 (COX-2) inhibitor. Produces potent analgesic, anti-inflammatory and antipyretic activities in vivo. Reported to produce fewer gastrointestinal side effects than standard NSAIDs. . |
Nimesulide Dilution Calculator
Nimesulide Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.2435 mL | 16.2174 mL | 32.4349 mL | 64.8698 mL | 81.0872 mL |
5 mM | 0.6487 mL | 3.2435 mL | 6.487 mL | 12.974 mL | 16.2174 mL |
10 mM | 0.3243 mL | 1.6217 mL | 3.2435 mL | 6.487 mL | 8.1087 mL |
50 mM | 0.0649 mL | 0.3243 mL | 0.6487 mL | 1.2974 mL | 1.6217 mL |
100 mM | 0.0324 mL | 0.1622 mL | 0.3243 mL | 0.6487 mL | 0.8109 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties.Nimesulide is a selective COX-2 inhibitor used in a variety of inflammatory, pain and fever states. After healthy volunteers
- 3,3'-Di-O-methylellagic acid 4'-glucoside
Catalog No.:BCN1431
CAS No.:51803-68-0
- Isomaculosidine
Catalog No.:BCN7069
CAS No.:518-96-7
- Cycleanine
Catalog No.:BCN8445
CAS No.:518-94-5
- Xanthopurpurin
Catalog No.:BCN6723
CAS No.:518-83-2
- Emodin
Catalog No.:BCN5649
CAS No.:518-82-1
- Corydaline
Catalog No.:BCN2342
CAS No.:518-69-4
- Tetrandrine
Catalog No.:BCN5955
CAS No.:518-34-3
- (-)-beta-Peltatin
Catalog No.:BCN3606
CAS No.:518-29-6
- Podophyllotoxin
Catalog No.:BCN5957
CAS No.:518-28-5
- Evodiamine
Catalog No.:BCN1092
CAS No.:518-17-2
- Dehydroglyasperin D
Catalog No.:BCN6829
CAS No.:517885-72-2
- Rengynic acid
Catalog No.:BCN5644
CAS No.:517883-38-4
- Oxoepistephamiersine
Catalog No.:BCN5645
CAS No.:51804-68-3
- Dihydrooxoepistephamiersine
Catalog No.:BCN5646
CAS No.:51804-69-4
- Raltegravir (MK-0518)
Catalog No.:BCC2137
CAS No.:518048-05-0
- KX1-004
Catalog No.:BCC5440
CAS No.:518058-84-9
- 2',4'-Dihydroxychalcone
Catalog No.:BCN5647
CAS No.:1776-30-3
- UMI-77
Catalog No.:BCC5567
CAS No.:518303-20-3
- Angiotensin 1/2 + A (2 - 8)
Catalog No.:BCC1037
CAS No.:51833-76-2
- Angiotensin (1-7)
Catalog No.:BCC1029
CAS No.:51833-78-4
- 3-MATIDA
Catalog No.:BCC7281
CAS No.:518357-51-2
- Allamandicin
Catalog No.:BCN4625
CAS No.:51838-83-6
- Licoricone
Catalog No.:BCN6818
CAS No.:51847-92-8
- 7-O-Methyleriodictyol
Catalog No.:BCN5648
CAS No.:51857-11-5
Quantification and In Silico Toxicity Assessment of Nimesulide and its Related Substances.[Pubmed:28168284]
J Chromatogr Sci. 2017 May 1;55(5):508-517.
Availability of analytical method which is compatible with both Ultra high performance liquid chromatography (UHPLC) and Liquid chromatography mass spectrometry to identify and quantify the impurities in pharmaceutical products is an advantage for drug product development; such analytical method was developed for Nimesulide using a fused core column. Ammonium acetate and methanol were used as mobile phase in the gradient elution at a detection wavelength 230 nm. Quality-by-design principles helped in identifying the critical method development parameters and design space. Limit of detection and the limit of quantification are 0.025 and 0.075%, respectively. Precision of the method is <0.4% RSD and correlation coefficient is >0.999 for Nimesulide and all related substances. Accuracy of Nimesulide ranged from 99.3 to 100.4% at assay concentration. Application of this method in stability analysis has been demonstrated by analyzing stressed samples. The method was validated for specificity, linearity, accuracy, precision and robustness in compliance with International Conference on Harmonization (ICH) Q2(R1). This is the first reported UHPLC method for the estimation of Nimesulide and its related substances. According to ICH M7 guidelines, all impurities were assessed for genotoxicity, LD50, skin sensitization, irritation potential and carcinogenicity using Derek and TOPKAT software. Combined knowledge of analytical and toxicology assessment will help in developing safe and quality product.
1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.[Pubmed:28011214]
Bioorg Med Chem Lett. 2017 Feb 1;27(3):518-523.
A new hybrid template has been designed by integrating the structural features of Nimesulide and the 1,2,3-triazole moiety in a single molecular entity at the same time eliminating the problematic nitro group of Nimesulide. The template has been used for the generation of a library of molecules as potential anticancer agents. A mild and greener CuAAC approach has been used to synthesize these compounds via the reaction of 4-azido derivative of Nimesulide and terminal alkynes in water. Three of these compounds showed promising growth inhibition (IC50 approximately 6-10muM) of A549, HepG2, HeLa and DU145 cancer cell lines but no significant effects on HEK293 cell line. They also inhibited PDE4B in vitro (60-70% at 10muM) that was supported by the docking studies (PLP score 87-94) in silico.
Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms.[Pubmed:27866353]
Folia Microbiol (Praha). 2017 Mar;62(2):169-174.
Certain non-steroidal anti-inflammatory drugs can inhibit fungal growth, fungal prostaglandin E2 production, and enzyme activation. This study aims to investigate the antifungal effect of Nimesulide against pathogenic filamentous fungi and yeast. The experiments detailed below were also designed to investigate whether the action is dependent on E2 fungal prostaglandins. Our data showed that Nimesulide exhibited potent antifungal activity, mainly against Trichophyton mentagrophytes (ATCC 9533) and Cryptococcus neoformans with MIC values of 2 and 62 mug/mL, respectively. This drug was also able to inhibit the growth of clinic isolates of filamentous fungi, such as Aspergillus fumigatus, and dermatophytes, such as T. rubrum, T. mentagrophytes, Epidermophyton floccosum, Microsporum canis, and M. gypseum, with MIC values ranging from 112 to 770 mug/mL. Our data also showed that the inhibition of fungal growth by Nimesulide was mediated by a mechanism dependent on PGE2, which led to the inhibition of essential fungal enzymes. Thus, we concluded that Nimesulide exerts a fungicidal effect against pathogenic filamentous fungi and yeast, involving the inhibition of fungal prostaglandins and fungal enzymes important to the fungal growth and colonization.
Nimesulide and 4'-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis.[Pubmed:28202577]
Drug Metab Dispos. 2017 May;45(5):441-448.
Nimesulide (NIM) is a classic nonsteroidal anti-inflammatory drug. However, some patients treated with NIM experienced cholestatic liver injury. For this reason, we investigated the potential mechanism underlying NIM-induced cholestasis by using in vivo and in vitro models. Oral administration of 100 mg/kg/day NIM to Wistar rats for 5 days increased the levels of plasma total bile acids, alkaline phosphatase, alanine aminotransferase, and aspartate aminotransferase by 1.49-, 1.31-, 1.60-, and 1.29-fold, respectively. In sandwich-cultured rat hepatocytes, NIM and 4'-hydroxyNimesulide (M1) reduced the biliary excretion index of d8-taurocholic acid (d8-TCA) and 5 (and 6)-carboxy-2',7'-dichlorofluorescein in a concentration-dependent manner, indicating the inhibition of the efflux transporters bile salt export pump and multidrug resistance-associated protein 2, respectively. In suspended rat hepatocytes, NIM and M1 inhibited the uptake transporters of d8-TCA for Na(+)-taurocholate cotransporting polypeptide at IC50 values of 21.3 and 25.0 muM, respectively, and for organic anion-transporting proteins at IC50 values of 45.6 and 39.4 muM, respectively. By contrast, nitro-reduced NIM and the further acetylated metabolite did not inhibit or only marginally inhibited these transporters at the maximum soluble concentrations. Inhibitory effects of NIM and M1 on human bile acid transporters were also confirmed using sandwich-cultured human hepatocytes. These data suggest that the inhibition of bile acid transporters by NIM and M1 is one of the biologic mechanisms of NIM-induced cholestasis.